Zum Hauptinhalt springen
Hochschulbibliothek Niederrhein

Suchergebnisse

Katalog

Mehr
12 Treffer

Suchmaske

Suchtipp für den Bereich Mehr: Wörter werden automatisch mit UND verknüpft. Eine ODER-Verknüpfung erreicht man mit dem Zeichen "|", eine NICHT-Verknüpfung mit einem "-" (Minus) vor einem Wort. Anführungszeichen ermöglichen eine Phrasensuche.
Beispiele: (burg | schloss) -mittelalter, "berufliche bildung"

Suchergebnisse einschränken oder erweitern

Aktive Suchfilter

12 Treffer

Sortierung: 
  1. Detailansicht für Treffer 1 öffnen
    [The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012].
    Penka, M ; Schwarz, J ; et al.
    In: Vnitrni lekarstvi, Jg. 59 (2013-06-01), Heft 6, S. 516-31
    academicJournal
    Wie komme ich dran?
  2. Detailansicht für Treffer 2 öffnen
    [Essential thrombocythaemia and other myeloproliferative disorders with thrombocythaemia treated with Thromboreductin. A report from the database of register for the 1st quarter of 2010].
    Penka, M ; Schwarz, J ; et al.
    In: Vnitrni lekarstvi, Jg. 56 (2010-06-01), Heft 6, S. 503-12
    academicJournal
    Wie komme ich dran?
  3. Detailansicht für Treffer 3 öffnen
    [The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin].
    Penka, M ; Schwarz, J ; et al.
    In: Vnitrni lekarstvi, Jg. 55 (2009-11-01), Heft 11, S. I-XII
    academicJournal
    Wie komme ich dran?
  4. Detailansicht für Treffer 4 öffnen
    [What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine].
    Penka, M ; Schwarz, J ; et al.
    In: Vnitrni lekarstvi, Jg. 54 (2008-07-01), Heft 7-8, S. 775-82
    academicJournal
    Wie komme ich dran?
  5. Detailansicht für Treffer 5 öffnen
    [Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006].
    Penka, M ; Schwarz, J ; et al.
    In: Vnitrni lekarstvi, Jg. 53 (2007-06-01), Heft 6, S. 653-61
    academicJournal
    Wie komme ich dran?
  6. Detailansicht für Treffer 6 öffnen
    [Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR].
    Penka, M ; Doubek, M ; et al.
    In: Vnitrni lekarstvi, Jg. 52 (2006-05-01), Heft 5, S. 498-503
    academicJournal
    Wie komme ich dran?
  7. Detailansicht für Treffer 7 öffnen
    [The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012]
    M, Penka ; J, Schwarz ; et al.
    In: Vnitrni lekarstvi, Jg. 59 (2013-07-02), Heft 6
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  8. Detailansicht für Treffer 8 öffnen
    [Essential thrombocythaemia and other myeloproliferative disorders with thrombocythaemia treated with Thromboreductin. A report from the database of register for the 1st quarter of 2010]
    M, Penka ; J, Schwarz ; et al.
    In: Vnitrni lekarstvi, Jg. 56 (2010-08-05), Heft 6
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  9. Detailansicht für Treffer 9 öffnen
    [The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin]
    M, Penka ; J, Schwarz ; et al.
    In: Vnitrni lekarstvi, Jg. 55 (2009-12-19), Heft 11
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  10. Detailansicht für Treffer 10 öffnen
    [What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine]
    M, Penka ; J, Schwarz ; et al.
    In: Vnitrni lekarstvi, Jg. 54 (2008-09-11), Heft 7-8
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  11. Detailansicht für Treffer 11 öffnen
    [Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006]
    M, Penka ; J, Schwarz ; et al.
    In: Vnitrni lekarstvi, Jg. 53 (2007-08-19), Heft 6
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
  12. Detailansicht für Treffer 12 öffnen
    [Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR]
    M, Penka ; M, Doubek ; et al.
    In: Vnitrni lekarstvi, Jg. 52 (2006-06-15), Heft 5
    Online unknown
    Zugriff:
    View record at OpenAIRE (Volltext)
    Wie komme ich dran?
xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -